We hypothesize that the anti-cancer effect of CCL9 observed in our in vivo research was a result of mostly anti-cancer leukocyte infiltration of the tumor or a thus far unknown CCL9-mediated mechanism preventing tumor progression beyond CCR1 signaling. This evidence concerns the gene CCR1 and cancer.